The North American Viral Hepatitis Elimination Summit, a collaboration of the American Association for the Study of the Liver (AASLD), Canadian Association for the Study of the Liver (CASL), and Mexican Association of Hepatology (AMH) will be delivered on Tuesday March 18th, 2025, at the Global Hepatitis Summit in Los Angeles.
March 18th, 2025
10AM to 5PM
Objectives:
- Bring high level attention to hepatitis elimination in North America
- Advance knowledge of strategies to reduce health disparities
- Explore novel programs that how to apply these more broadly across countries in North America
Introductions and Overview
Co-Chairs: Jordan Feld (CASL), Norah Terrault (AASLD), Aldo Torre (AMH) Moderators: Jordan Feld, Aldo Torre, Norah Terrault / John Ward
NAVHES Session #1 - Taking Stock (profiles in NA): trends, progress towards targets and big scale initiatives
Moderators: John Ward & Carla Coffin
Canada – Canada’s STBBI Action Plan 2024-2030
Mexico – Expansion of HCV management in primary care
United States --- US HCV elimination in transition
Risha Irvin, Health Equity Program Director, Johns Hopkins Health System
Session 1 Panel Discussion
NAVHES Session #2 - Diagnostics with the goal of increasing treatment
Moderators: Norah Terrault & Aldo Torre
HCV POCT and barriers to test & treat approach
Andrew Aronsohn, Associate Professor of Medicine, University of Chicago
HBV testing – what needs to ∆ in policies & practice (qHBsAg, HBV POCT)
Carla Coffin, Professor Cumming School of Medicine University of Calgary
HDV: reflex testing, status of anti-HDV & RNA testing in NA
Robert Gish, Principal, Robert G Gish Consultants LLC
Session 2 Panel Discussion
NAVHES Session #3 - Vaccination – an important cornerstone in Prevention
Moderators: Jordan Feld & Graciela Castro
Suggest Catch-up HepB Vaccination Strategies for all or at risk adults
HCV Vaccine trials in NA status report
Kimberly Page, Professor, University of New Mexico Health Sciences Center
Lunch Symposium
NAVHES Session #4 - Prevention Beyond Vaccination
Next Steps in Elimination of MTCT of HBV and HCV in North America
Mia Biondi, Assistant Professor at York University
Liver cancer in VH in North America – surveillance challenges and solutions
Session 4 Panel Discussion
NAVHES Session #5- Health equity: Delivering VH care in persons using drugs
Moderators: Norah Terrault & Aldo Torre
Prevention of HCV among PWID in Mexico
Fatima Higuera, Head of Gastroenterology and Hepatology, Mexico's General Hospital "Dr. Eduardo Liceaga
PWIDs – novel programs in U.S.
Alain H Litwin, Professor, Clemson University School of Health Research
Supervised injection sites and SSPs in Canada
Bernadette Lettner, Ontario Hepatitis C Elimination Lead: Clinical Training, Guidance and Monitoring, UHN
Session 5 Panel Discussion
Wrap-up and Next Steps - Blueprint/Roadmap strategy
Moderators: John Ward, Norah Terrault, Jordan Feld & Aldo Torre
